Industry News

May 21, 2013

The Risk To Light-Skinned People Of Sun Exposure Highlighted By Study Of Young Israelis

A new study conducted using extensive medical records of over one million Israeli adolescents before military service shows clearly how exposure to the Israeli sun of young, light-skinned children increases substantially the risk of cutaneous melanoma (a serious form of skin cancer). The incidence of cutaneous melanoma is on the rise in all parts of the world where light-skinned people live... Read More
May 21, 2013

Risk Of Melanoma Increased By Inflammatory Bowel Disease

Patients with inflammatory bowel disease(IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. The findings were presented at the Digestive Disease Week 2013 conference in Orlando, Fla. More than 1... Read More
May 21, 2013

Epigenetic Regulators And NF-Kappa B May One Day Be Targeted For The Treatment Of Cancer

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth. Scientists call this Jekyll-and-Hyde molecule NF-kappa B. In healthy cells, it is a powerful "first responder," a vital part of the body's immune and inflammatory responses... Read More
May 21, 2013

Few Simple Steps To Prevent Skin Cancer This Summer

Skin cancer remains the most common cancer in the U.S., and as summer is quickly approaching, Americans are encouraged to take a few simple steps to protect their health and prevent skin cancer throughout this upcoming season. The U.S... Read More
May 20, 2013

Phase III Trial Of L-BLP25 In Patients With Non-Small Cell Lung Cancer (START) - Primary Endpoint Of Significantly Improving Overall Survival Not Met

Confirmed: Primary endpoint of significantly improving overall survival not met Merck Serono, a division of Merck, Darmstadt, Germany, today announced detailed results from the randomized Phase III START* trial of its investigational MUC1 antigen-specific cancer immunotherapy L-BLP25 (formerly referred to as Stimuvax) in patients with unresectable, locally advanced Stage III... Read More
May 20, 2013

Outcome In Head And Neck Cancer Predicted By Genetic Diversity Within Tumors

A new measure of the heterogeneity - the variety of genetic mutations - of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer... Read More
May 20, 2013

Software May Allow Doctors To Track Progression Of Cancer, Response To Treatment, And Risk Of Relapse

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual cells. These technologies have led to new challenges, however, as scientists now struggle with how to make sense of the resulting trove of data. Now a solution may be at hand... Read More
May 20, 2013

Ground-Breaking View Of Colon Provided By New Colonoscope

A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented at Digestive Disease Week® (DDW). Additional research focuses on optimizing the minimal withdrawal time for colonoscopies and exploring safer methods for removing polyps. During colonoscopy, doctors use a device called a colonoscope to examine the colon... Read More
May 20, 2013

New Methods For Managing Digestive Health

Research presented at Digestive Disease Week® (DDW) explores new methods for managing digestive health through diet and lifestyle. Individuals suffering from Crohn's disease are often plagued by reduced muscle strength, fatigue and poor quality of life. These symptoms can remain even when patients are in remission... Read More
May 20, 2013

UK Aims To Make Genetic Testing Available To All Cancer Patients

A research program that should eventually allow all cancer patients to have access to genetic testing has been launched with £2.7 million ($4 million) funding from the Wellcome Trust... Read More
Next Page